Team in Munich
Therapeutical Product Index
Production & Control
Stability, shelf life & Transport
A Denk Pharma Initiative for Trust in Quality Medicines
Imatinib Denk 100 mg
Imatinib Denk 400 mg
Guideline-recommended for the treatment of chronic myeloid leukemia (CML).
Easy to take (orally, once daily with a meal and a large glass of water).
May be dispersed in fluid if patient has swallowing problems.
Imatinib Denk 100 mg in comparison with the original product: